Bausch Health Companies | VRX - Operating Expenses

Stock Price
7.77
Daily Change
-0.12 -1.52%
Monthly
-23.90%
Yearly
-25.29%
Q1 Forecast
7.62

Bausch Health Companies reported $1.96B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Amgen USD 5.13B 1.39B Sep/2025
ANI Pharmaceuticals USD 505.82M 309.62M Sep/2025
Aurora Cannabis CAD 146.03M 27.79M Sep/2025
Bausch Health Companies USD 1.96B 109M Sep/2025
Biogen USD 1.88B 81.4M Sep/2025
Bristol-Myers Squibb USD 18.55B 10.06B Sep/2025
Canopy Growth CAD 80.99M 8.64M Sep/2025
Corcept Therapeutics USD 197.42M 29.66M Sep/2025
Danaher USD 5.34B 45.74B Dec/2025
Drreddys Laboratories INR 72.94B 4.33B Dec/2025
Eli Lilly USD 9.21B 677.8M Sep/2025
Gilead Sciences USD 4.26B 95M Sep/2025
Novo Nordisk DKK 42.77B 3.48B Jun/2025
Pacira USD 166.36M 4.5M Sep/2025
Perrigo USD 949.9M 50.8M Sep/2025
Prestige Brands USD 194.44M 16.67M Sep/2025
Supernus Pharmaceuticals USD 252.29M 98.98M Sep/2025
Vertex Pharmaceuticals USD 1.84B 27.1M Sep/2025
Zoetis USD 5.4B 3.94B Sep/2025